Moderately high folic acid supplementation exacerbates experimentally induced liver fibrosis in rats

Experimental Biology and Medicine

Volumn 233, Issue 1, 2008, Pages 38-47

  Marsillach, Judit ^a   Ferré, Natàlia ^b   Camps, Jordi ^a   Riu, Francesc ^a   Rull, Anna ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Apoptosis; Fibrosis; Folic acid; Gene expression; Nutrition

Indexed keywords

BILIRUBIN; CARBON TETRACHLORIDE; COLLAGEN; FOLIC ACID; INHIBITOR OF APOPTOSIS PROTEIN 2; MATRILYSIN; PROCOLLAGEN; SERUM ALBUMIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FOLLOW UP; GENE EXPRESSION; HEPATITIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION; LIVER INJURY; LIVER PARENCHYMA; LIVER TOXICITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STELLATE CELL; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ANIMALIA; RATTUS;

EID: 37549052154     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0703-RM-59     Document Type: Article

References (54)

1. Crott JW, Mashiyama ST, Ames BN, Fenech M. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 10:1089-1096, 2001.
2. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94:3290-3295, 1997.
3. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 12:1491-1497, 1998.
4. Kim YI, Pogribny IP, Basnakian AG, Miller JW, Selhub J, James SJ, Mason JB. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr 65:46-52, 1997.
5. Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med 229:988-995, 2004.
6. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139, Fed Regist 61:8781-8807, 1996.
7. Honein MA, Paulozzi JL, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285: 2981-2986, 2001.
8. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 226:243-270, 2001.
9. Campbell NR. How safe are folic acid supplements? Arch Intern Med 156:1638-1644, 1996.
10. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80:1123-1128, 2004.
11. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut 55:1387-1389, 2006.
12. Kim YI, Salomon RN, Graeme-Cook F, Choi SW, Dmith DE, Dallal GE, Mason JB. Dietary folate protects against the development of macroscopic colonic neoplasia in a dose responsive manner in rats. Gut 39:732-740, 1996.
13. Van Guelpen B, Huldtin J, Johansson I, Hallmans G, Stenling R, Riboli E, Winkvist A, Palmqvist R. Low folate levels may protect against colorectal cancer. Gut 55:1461-1466, 2006.
14. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10:66-88, 1999.
15. Kim YI. Role of folate in colon cancer development and progression. J Nutr 133:3731S-3739S, 2003.
16. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132:2413S-2418S, 2002.
17. Cao DZ, Sun WH, Ou XL, Yu Q, Yu T, Zhang YZ, Wu ZY, Xue QP, Cheng YL. Effects of folic acid on epithelial apoptosis and expression of Bcl-2 and p53 in premalignant gastric lesions. World J Gastroenterol 11:1571-1576, 2005.
18. Buchman AL. Total parenteral nutrition: challenges and practice in the cirrhotic patient, Transplant Proc 28:1659-1663, 2006.
19. Stratton RJ, Smith TR. Role of enteral and parenteral nutrition in the patient with gastrointestinal and liver disease. Best Pract Res Clin Gastroenterol 20:441-466, 2006.
20. Cabré M, Ferré N, Folch J, Paternáin JL, Hernández M, Del Castillo D, Joven J, Camps J. Inhibition of hepatic cell nuclear DNA fragmentation by zinc in carbon tetrachloride-treated rats. J Hepatol 31:228-234, 1999.
21. Neuman MG. Cytokines-central factors in alcoholic liver disease. Alcohol Res Health 27:307-316, 2003.
22. Halsted CH, Villanueva JA, Devlin AM. Folate deficiency, methionine metabolism, and alcoholic liver disease. Alcohol 27:169-172, 2002.
23. Esfandiari F, Villanueva JA, Wong DH, French SW, Halsted CH. Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am J Physiol Gastrointest Liver Physiol 289:54-63, 2005.
24. Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117:539-548, 2007.
25. Arthur MJ, Mann DA, Iredale JP. Tissue inhibitors or metalloproteinases, hepatic stellate cells and liver fibrosis. J Gastroenterol Hepatol 13 (Suppl):S33-S38, 1998.
26. Jiménez W, Clària J, Arroyo V, Rodés J. Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease. J Gastroentrol Hepatol 7:90-97, 1992.
27. Gassó M, Rubio M, Varela G, Cabré M, Caballería J, Alonso E, Deulofeu R, Camps J, Giménez A, Pajares M, Parés A, Mato JM, Rodés J. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol 25:200-205, 1996.
28. Goulter AB, Harmer DW, Clark KL. Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue. BMC Genomics 7:34-43, 2006.
29. Goldshmidt O, Yeikilis R, Mawasi N, Paizi M, Gan N, Ilan N, Pappo O, Vlodavsky I, Spira G. Heparanase expression during normal liver development and following partial hepatectomy. J Pathol 203:594-602, 2004.
30. Sancho-Bru P, Bataller R, Gasull X, Colmenero J, Khurdayan V, Gual A, Nicolas JM, Arroyo V, Ginés P. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers. J Hepatol 43:272-282, 2005.
31. Huang RFS, Ho YH, Lin HL, Wei JS, Liu TZ. Folate deficiency induces a cell cycle-specific apoptosis in HepG2 cells. J Nutr 129:25-31, 1999.
32. Fernández MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, Kurzchalia T, Tebar F, Enrich C, Parton RG, Pol A. Caveolin-1 is essential for liver regeneration. Science 313:1628-1632, 2006.
33. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Sem Liv Dis 21:351-372, 2001.
34. Luckey SW, Petersen DR. Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp Mol Pathol 71:226-240, 2001.
35. Hua J, Qiu de K, Li JQ, Li EL, Chen XY, Peng YS. Expression of Toll-like receptor 4 in rat liver during the course of carbon tetrachloride-induced liver injury. J Gastroenterol Hepatol 22:862-869, 2007.
36. Israels LG, Israels ED. Apoptosis. Stem cells 17:306-313, 1999.
37. Cohen GM. Caspase: the executioners of apoptosis. Biochem J 326:1-16, 1997.
38. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424, 1999.
39. 2+ release from the endoplasmic reticulum and suppressing Bcl-2 expression. J Biol Chem 277:31381-31389, 2002.
40. Wang J, Li W, Min J, Ou Q, Chen J, Song E. Intrasplenic transplantation of allogenic hepatocytes modified by BCL-2 gene protects rats from acute liver failure. Transplant Proc 36:2924-2926, 2004.
41. Benyon RC, Arthur MJP. Extracellular matrix degradation and the role of hepatic stellate cells. Sem Liv Dis 21:373-384, 2001.
42. Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M, Fleeming P, Manns MP, Boeker KH. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J Hepatol 34:239-247, 2001.
43. García-Trevijano ER, Berasain C, Rodríguez JA, Corrales FJ, Arias R, Martín-Duce A, Caballería J, Mato JM, Avila MA. Hyperhomocysteinemia in liver cirrhosis. Mechanisms and role in vascular and hepatic fibrosis. Hypertension 38:1217-1221, 2001.
44. Malinow MR, Duell PB, Williams MA, Kruger WD, Evans AA, Anderson PH. Short term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations. Lipids 36:S27-S32, 2002.
45. Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270:14313-14318, 1995.
46. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435:39-44, 1998.
47. Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, Lauro D, Mauriello A, Smookler DS, Sbraccia P, Sesti G, Lee DC, Khokha R, Accili D, Lauro R. Timp 3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α. J Clin Invest 115:3494-3505, 2005.
48. -/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nature Genet 36:969-977, 2004.
49. Roncalés M, Achón M, Manzarbeitia F, Maestro de las Casas C, Ramírez C, Varela-Moreiras G, Pérez-Miquelsanz J. Folic acid supplementation for 4 weeks affects liver morphology in aged rats. J Nutr 134:1130-1133, 2004.
50. Woo CWH, Prathapasinghe GA, Siow YL, Karmin O. Hyperhomocysteinemia induces liver injury in rat: protective effect of folic acid supplementation. Biochim Biophys Acta 176:656-665, 2006.
51. Crott JW, Choi SW, Órdovas JM, Ditelberg JS, Mason JB. Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: implications for carcinogenesis. Carcinogenesis 25:69-76, 2004.
52. Baydar TB, Nagymajtényi L, Isimer A, Sahin G. Effect of folic acid supplementation on aluminum accumulation in rats. Nutrition 21:406-410, 2005.
53. Achon M, Alonso-Aperte E, Reyes L, Ubeda N, Varela-Moreiras G. High-dose folic acid supplementation in rats: effects on gestation and the methionine cycle. Br J Nutr 83:177-183, 2000.
54. Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. In: American Society of Hematology, Ed. Hematology. Washington, DC: pp 68-81, 2003.